Investor Alert - Cybin: Changing the Mental Healthcare Experience

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a singl …

January 17, 2022
Request Investor InfoRequest Investor Info
Cybin

On a mission to revolutionize mental healthcare

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.

Their work includes the development of new drug molecules, with a focus on optimizing treatment outcomes through innovative drug delivery systems, concurrent therapy regimens, and technology-driven patient analytics.

For more information on Cybin Inc. (NEO: CYBN, NYSE AMERICAN: CYBN) please click the request investor info button.

stock market
stock picks
stocks
stocks to buy

You might also like

Metals & Mining
January 26, 2026

CEO Clips – ONGold Resources: Advancing High-Grade Gold & Strategic Critical Minerals in Canada

ONGold Resources is building a diversified portfolio of projects positioned to benefit from rising global demand for both precious and critical minerals.

This is some text inside of a div block.
Metals & Mining
January 26, 2026

ONGold Resources: Focused on Gold, Copper & Critical Minerals

ONGold Resources is advancing a growing portfolio of projects across Ontario and Manitoba, centered on gold, copper, and strategically important critical minerals.

This is some text inside of a div block.
Sitka Gold: Intensifies Discovery Momentum with Yukon Drill Program and Strategic Advancements
Metals & Mining
January 22, 2026

Sitka Gold: Intensifies Discovery Momentum with Yukon Drill Program and Strategic Advancements

This is some text inside of a div block.
Subscribe and receive the investor Info